Drug Combination Details
| General Information of the Combination (ID: C88698) | |||||
|---|---|---|---|---|---|
| Name | Metformin NP Info | + | Ertugliflozin Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Type 2 diabetes mellitus
[ICD-11: 5A11]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vivo Model | Clinical trial | |||||
| Experimental
Result(s) |
The fixed-dose combination of ertugliflozin with metformin is an effective combination that is conveniently administered and may improve medication adherence and persistence. | |||||
| References | ||||
|---|---|---|---|---|
| Reference 1 | Fixed-dose combination of ertugliflozin and metformin hydrochloride for the treatment of type 2 diabetes. Expert Rev Endocrinol Metab. 2019 Mar;14(2):75-83. | |||
